Blood test may help predict survival from advanced prostate cancer

A simple blood test may help doctors decide the best way to treat a man with advanced prostate cancer.

A phase 3 clinical trial has shown that circulating tumor cell (CTC) counts can predict which men are likely to respond to standard treatment and live longest and which might benefit from more aggressive new drug trials.

Advertisement